Cipla JV Gets Process Patent for Stem Cell Drug From Japan

New Delhi: Drug major Cipla on Monday said its joint venture firm Stempeutics Research has received a process patent from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia (CLI). “The new patent …

[Read the full article here]

Comments are closed.